We observed a similar phenomenon in vitro, where growth of B16 tumor cells lacking type I or II interferon signaling (but not both) were inhibited by tumor- specific pmel T cells compared to non-specific T cells, provided the alternate interferon pathway was activated (p < 0.0001). This evidence concerns the gene SGCG and neoplasm.